Date Initiated by Firm | April 12, 0013 |
Date Posted | May 29, 2013 |
Recall Status1 |
Terminated 3 on September 28, 2013 |
Recall Number | Z-1422-2013 |
Recall Event ID |
65089 |
Product Classification |
Discs, strips and reagents, microorganism differentiation - Product Code JTO
|
Product | BBL DrySlide PYR Kit, catalog number 231747
Product Usage:
Presumptive diagnostic aid for group A streptococci and group D enterococci bacteria. |
Code Information |
PYR kit - lot 2276481 with expiration date 09/30/13 |
Recalling Firm/ Manufacturer |
Becton Dickinson & Co. BD Diagnostic Systems 7 Loveton Circle Sparks MD 21152-0999
|
For Additional Information Contact | Gail Claiborne 410-316-4000 |
Manufacturer Reason for Recall | In-vitro diagnostic agents were placed into incorrect packaging for distribution to microbiological laboratories. |
FDA Determined Cause 2 | Mixed-up of materials/components |
Action | BD Diagnostic Systems sent an Urgent Product Recall" letter dated April 2013 to all affected consignees and end users. The letter identified the affected product, problem and actions to be taken. The notice instructed consignees and end users to discontinue use of the products, discard remaining products, and return a completed response form. Consignees were requested to provide contact information for end users who received recalled product in distribution, to allow for recall notice. The letter included instructions to report injuries and/or illnesses to Medwatch, and address recall inquiries to BD Technical Services at 1-800-638-8663. |
Quantity in Commerce | 610 total test kits (PYR and Oxidase) |
Distribution | Worldwide Distribution - USA Nationwide and tthe countries of Australia, Canada, Europe, Hong Kong, Mexico, New Zealand, Singapore, and Taiwan. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|